logo

VYGR

Voyager Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.13 / 10
Netural

Analyst coverage is limited but overwhelmingly bullish (1 Strong Buy, 0 others). Simultaneously, fund flow shows a 7.09/10 positive score with negative trends across block, small, medium, large, and extra-large patterns, hinting at underlying buying interest despite short-term outflows. This divergence between strong analyst conviction and mixed fund flows adds complexity to the near-term outlook.

FundamentalSentiment(5.13)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-11-12
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of VYGR?
  • VYGR holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.13/10 (Netural).